Related Experiment Videos
Nerve growth factor treatment in dementia
1Department of Clinical Neuroscience, Karolinska Institute, Huddinge University Hospital, Sweden.
Alzheimer Disease and Associated Disorders
|June 13, 2000
Summary
Nerve growth factor (NGF) shows promise for treating Alzheimer disease by protecting and regenerating brain cells. Clinical trials suggest NGF may counteract neuronal degeneration and improve cognitive function in Alzheimer patients.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Alzheimer disease (AD) and dementia prevalence are increasing with longevity.
- Neurotrophic factors are crucial for neuronal development, maintenance, and protection.
- Cholinergic neuron degeneration is a hallmark of AD, impacting cognitive function.
Purpose of the Study:
- To investigate the potential of neurotrophic factors, specifically nerve growth factor (NGF), as a treatment for Alzheimer disease.
- To explore NGF's ability to counteract cholinergic degeneration and stimulate neuronal sprouting in AD.
Main Methods:
- Review of animal studies on NGF's effects on cholinergic neurons.
- Presentation of data from a clinical trial involving intraventricular NGF infusion in Alzheimer patients.
Main Results:
- Animal studies demonstrate NGF sensitivity and dependency of cholinergic neurons.
- Clinical trial data on NGF's effects on cognition, dosage, side effects, and administration routes will be presented.
Conclusions:
- NGF holds therapeutic potential for Alzheimer disease by targeting cholinergic degeneration.
- Further research and clinical trials are needed to optimize NGF delivery and efficacy for AD treatment.